Second degree AV block other imaging findings: Difference between revisions
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Second degree AV block}} | {{Second degree AV block}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{Sara.Zand}} | ||
==Overview== | ==Overview== | ||
[[Transesophageal echocardiography]], [[computed tomography]], [[cardiac magnetic resonance imaging]] ([[MRI]]),or [[nuclear imaging]] are other advanced | [[Transesophageal echocardiography]], [[computed tomography]], [[cardiac magnetic resonance imaging]] ([[MRI]]), or [[nuclear imaging]] are other advanced imagings that can be used in suspicion of [[structural heart disease]] in [[patients]] presented with [[bradycardia]] or [[bundle branch block]]. | ||
==Other imaging findings== | ==Other imaging findings== |
Latest revision as of 06:08, 12 July 2021
Second degree AV block Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Second degree AV block other imaging findings On the Web |
American Roentgen Ray Society Images of Second degree AV block other imaging findings |
Risk calculators and risk factors for Second degree AV block other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2]
Overview
Transesophageal echocardiography, computed tomography, cardiac magnetic resonance imaging (MRI), or nuclear imaging are other advanced imagings that can be used in suspicion of structural heart disease in patients presented with bradycardia or bundle branch block.
Other imaging findings
Recommendations for imaging study in Bradycardia or Conduction disorder |
Advanced imaging : (Class IIa, Level of Evidence C) |
❑ In suspicion of structural heart disease in patients presented with bradycardia or bundle branch block, transesophageal echocardiography, computed tomography, cardiac magnetic resonance imaging (MRI),or nuclear imaging is recommended |
Cardiac imaging : (Class III, Level of Evidence B) |
❑ Routine cardiac imaging is not recommended in patients with asymptomatic sinus bradycardia or first-degree atrioventricular block and no clinical evidence of structural heart disease |
Abbreviations:
LBBB: Left bundle branch block
The above table adopted from 2018 AHA/ACC/HRS Guideline[1] |
---|
References
- ↑ Kusumoto, Fred M.; Schoenfeld, Mark H.; Barrett, Coletta; Edgerton, James R.; Ellenbogen, Kenneth A.; Gold, Michael R.; Goldschlager, Nora F.; Hamilton, Robert M.; Joglar, José A.; Kim, Robert J.; Lee, Richard; Marine, Joseph E.; McLeod, Christopher J.; Oken, Keith R.; Patton, Kristen K.; Pellegrini, Cara N.; Selzman, Kimberly A.; Thompson, Annemarie; Varosy, Paul D. (2019). "2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society". Circulation. 140 (8). doi:10.1161/CIR.0000000000000628. ISSN 0009-7322.